Clinical Trials Sponsored by OHSU Knight Cancer Institute

Total 267 results

OHSU Knight Cancer Institute

Active, not recruiting

Blood Vessel Patterns in Small Choroidal Tumors

Small Posterior Choroidal Tumors

United States
OHSU Knight Cancer Institute

Withdrawn

N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

Primary Peritoneal Carcinoma | Epithelial Ovarian Carcinoma | Ovarian Carcinoma, Stage 3 or 4

United States
OHSU Knight Cancer Institute

Completed

Molecular Markers in Thyroid Cancer

Thyroid Cancer

United States
OHSU Knight Cancer Institute

Recruiting

An Exercise Prehabilitation Intervention for Improving Mobility and Recovery Outcomes in Patients Undergoing Head and Neck Cancer Surgery

Head and Neck Carcinoma

United States
OHSU Knight Cancer Institute

Completed

Vascular Response to Brachytherapy Using Functional OCT

Uveal Melanoma

United States
OHSU Knight Cancer Institute

Completed

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

Chronic Neutrophilic Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative

United States
OHSU Knight Cancer Institute

Completed

MRI Assessment of Leukemia Response to Therapy

Acute Myelogenous Leukemia

United States
OHSU Knight Cancer Institute

Completed

Docetaxel in Treating Patients With Stage IV Prostate Cancer

Pain | Prostate Cancer

United States
OHSU Knight Cancer Institute

Completed

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

Breast Cancer | Menopause | Vulvodynia | Dyspareunia

United States
OHSU Knight Cancer Institute

Completed

Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis

Melanoma

United States
OHSU Knight Cancer Institute

Terminated

Abraxane/Bevacizumab

Ovarian Cancer | Peritoneal Cancer

United States
OHSU Knight Cancer Institute

Completed

Comparing Warm Versus Cool Temperature Water During Colonoscopy

Colonoscopy

United States
OHSU Knight Cancer Institute

Not yet recruiting

Use Of Indocyanine Green In Pancreas Surgery

Pancreatic Carcinoma

United States
OHSU Knight Cancer Institute

Not yet recruiting

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Atrial Fibrillation | Esophageal Carcinoma

United States
OHSU Knight Cancer Institute

Recruiting

Impact of Dietary Fiber Supplementation on Colonic Mucosal Microbiome

Benign Colorectal Neoplasm | Non-Neoplastic Anal Disorder

United States
OHSU Knight Cancer Institute

Terminated

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Leukemia

United States
OHSU Knight Cancer Institute

Active, not recruiting

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute

Completed

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Cancer

United States
OHSU Knight Cancer Institute

Terminated

Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer

Pain | Unspecified Adult Solid Tumor, Protocol Specific

United States
OHSU Knight Cancer Institute

Completed

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

Hot Flashes | Neutropenia | Fever | Unspecified Adult Solid Tumor, Protocol Specific | Infection | Sweating

United States
OHSU Knight Cancer Institute

Completed

Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
Sanofi

Completed

Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

Pancreatic Cancer

United States
OHSU Knight Cancer Institute
Pfizer

Terminated

Pre-Prostatectomy Celecoxib or Placebo

Prostate Cancer | Adenocarcinoma of the Prostate

United States
OHSU Knight Cancer Institute
Natera, Inc.

Recruiting

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Stage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8

United States
OHSU Knight Cancer Institute
Movember Foundation

Completed

Internet-Based Exercise and Diet Support in Prostate Cancer Survivors

Cancer Survivor | Prostate Carcinoma

United States
OHSU Knight Cancer Institute
Lance Armstrong Foundation

Completed

Exercise for Physical Health in Men With Prostate Cancer

Osteoporosis | Prostatic Neoplasm

United States
OHSU Knight Cancer Institute
Ariad Pharmaceuticals

No longer available

Compassionate Use Ponatinib

Chronic Myeloid Leukemia | Philadelphia Chromosome Positive (Ph+) Leukemias

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

Childhood Brain Neoplasm | Recurrent Childhood Brain Neoplasm

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Exercise and Nutrition Program in Improving Physical Activity and Dietary Behavior in Non-Active, Overweight, or Obese Latinas

Obesity | Overweight

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms | Unusual Cancers of Childhood

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Lymphoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML

Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy

Breast Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms | Nausea and Vomiting

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma (Protocol-A)

Lymphoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Prostate Cancer
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

Unspecified Adult Solid Tumor, Protocol Specific | Infection

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Stage IIA Adult Soft Tissue Sarcoma | Stage IIB Adult Soft Tissue Sarcoma | Stage IIC Adult Soft Tissue Sarcoma
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Lymphoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Sarcoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers

Myelodysplastic Syndromes | Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Tissue Sample Collection From Patients With Fanconi Anemia

Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Fanconi Anemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation Therapy

Prostate Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (Bu Flu TBI)

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Myelodysplastic/Myeloproliferative Neoplasms

United States

Clinical Trials Sponsored by OHSU Knight Cancer Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations